Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.
Summary of CGRP mAbs
| Drug | Mechanism | Indication | Dosing | FDA approved | Availability in the UAE |
|---|---|---|---|---|---|
| Erenumab | Block CGRP receptor | Prophylactic | Monthly, subcutaneous | 2018 | Yes |
| Eptinezumab | Bind to CGRP ligand | Prophylactic | Quarterly, intravenous | 2020 | Yes |
| Glacanezumab | Bind to CGRP ligand | Prophylactic | Monthly, subcutaneous | 2018 | Yes |
| Fremanezumab | Bind to CGRP ligand | Prophylactic | Monthly or quarterly, subcutaneous | 2018 | No |
